Blood CancerInfo Center
Leukemia Drug Granted Accelerated Review
The U.S. Food and Drug Administration has granted Ariad Pharmaceuticals, Inc. accelerated review of its drug ponatinib to treat patients who have chronic myeloid leukemia ( CML ) that doesn’t respond to current medications.
Former Senator Arlen Specter Dies
The Senator who served the state of Pennsylvania for longer than anyone in history – Arlen Specter – has lost his years-long battle with cancer. He died of complications from non-Hodgkin's lymphoma (NHL) in his Philadelphia home this morning.
Recycling the Cyclin D1 Target Theory
Non-Hodgkin lymphoma is a cancer that starts in the lymphatic system, that’s made up of tiny tubes that run throughout the body. One subtype of non-Hodgkin lymphoma (NHL) – mantle cell lymphoma – needs more treatment options and research is under way to find those solutions.
Soaring Melanoma Risks for Some
Melanoma – the deadliest form of skin cancer – is increasing in this country for a number of reasons, including tanning beds. Some cancer patients are especially at risk and need to be especially vigilant of their skin.
Cancer Goes To the Movies
If you’re familiar with Debra Winger, you may know she’s died from cancer at least a couple times – in her movies Terms of Endearment and Shadowlands . While cancer can make for heart-wrenching drama, such bleak portrayals of the disease are far from the truth.
Helping Cancer Cells Die
One of the genes that helps to keep cancer from ever forming is the p53 gene. It works by blocking cancer cells from killing themselves. When p53 is messed up in some way, cancer cells go to town and wreak havoc.
AIDS and Cancer Links
People living with HIV (human immunodeficiency virus) are at greater risk of various forms of cancer. In fact, when these cancers appear, it means the virus has turned into full-blown AIDS (acquired immunodeficiency syndrome).
New Chronic Myeloid Leukemia Drug
Chronic myeloid leukemia often responds to first-line treatment. Gleevec ( imatinib ) is the standard first-line medication. The disease usually quiets for a time, then comes back. A new drug has been approved to treat this blood and bone marrow cancer.
Monitoring the Monitoring of CML Patients
When monitored and managed properly, the outlook is quite good for people living with chronic myeloid leukemia ( CML ). There are three targeted therapies that are effective in controlling this disease. One of the keys to success is close monitoring.
New Genetic Signature for Leukemia
So what’s a genetic signature you ask? Basically it’s a set of genes in a cell that are involved in how disease starts, grows and spreads. This is hugely complicated and exciting science.